Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose Loureiro Amigo

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|May 14, 2019
Risk of ischaemic events at giant cell arteritis diagnosis according to PET/CT findingsJaume Mestre-Torres, Marc Simó-Perdigó, Fernando Martínez-Valle, et al.
Clinical and Experimental Rheumatology|December 17, 2021
Serum CXCL13, BAFF, IL-21 and IL-22 levels are related to disease activity and lymphocyte profile in primary Sjögren's syndromeJose Loureiro-Amigo, Clara Franco-Jarava, Janire Perurena-Prieto, et al.
Rheumatology (Oxford, England)|February 6, 2026
ANCA testing in real-world clinical practice: diagnostic performance and predictive value in a Spanish cohortJose Loureiro-Amigo, Jaume Mestre-Torres, Ana Marín-Sánchez, et al.
Trials|January 12, 2021
Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trialIñigo Les Bujanda, Jose Loureiro-Amigo, Ferran Capdevila Bastons, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|February 11, 2016
[Infective endocarditis in adult patients with congenital heart disease. Experience from a reference centre]Jose Loureiro-Amigo, Nuria Fernández-Hidalgo, Antonia Pijuan-Domènech, et al.
International Journal of Antimicrobial Agents|May 11, 2019
Non-intravenous carbapenem-sparing antibiotics for definitive treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamase (ESBL) or AmpC β-lactamase: A propensity score studyYolanda Meije, Carles Pigrau, Núria Fernández-Hidalgo, et al.
Plos One|October 10, 2022
Persistent COVID-19 symptoms 1 year after hospital discharge: A prospective multicenter studyJudit Aranda, Isabel Oriol, Lucía Feria, et al.
Antibiotics (Basel, Switzerland)|May 27, 2023
Changing Trends in the Global Consumption of Treatments Used in Hospitalized Patients for COVID-19: A Time Series Multicentre StudyJudit Aranda, Jose Loureiro-Amigo, Anna Murgadella, et al.
Frontiers in Medicine|March 17, 2022
Methylprednisolone Pulses in Hospitalized COVID-19 Patients Without Respiratory Failure: A Randomized Controlled TrialIñigo Les, Jose Loureiro-Amigo, Ferran Capdevila, et al.
Plos One|January 21, 2022
Use of glucocorticoids megadoses in SARS-CoV-2 infection in a spanish registry: SEMI-COVID-19Cristina Lavilla Olleros, Cristina Ausín García, Alejandro David Bendala Estrada, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
European Journal of Nuclear Medicine and Molecular Imaging|May 14, 2019
Risk of ischaemic events at giant cell arteritis diagnosis according to PET/CT findingsJaume Mestre-Torres, Marc Simó-Perdigó, Fernando Martínez-Valle, et al.
Clinical and Experimental Rheumatology|December 17, 2021
Serum CXCL13, BAFF, IL-21 and IL-22 levels are related to disease activity and lymphocyte profile in primary Sjögren's syndromeJose Loureiro-Amigo, Clara Franco-Jarava, Janire Perurena-Prieto, et al.
Rheumatology (Oxford, England)|February 6, 2026
ANCA testing in real-world clinical practice: diagnostic performance and predictive value in a Spanish cohortJose Loureiro-Amigo, Jaume Mestre-Torres, Ana Marín-Sánchez, et al.
Trials|January 12, 2021
Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trialIñigo Les Bujanda, Jose Loureiro-Amigo, Ferran Capdevila Bastons, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|February 11, 2016
[Infective endocarditis in adult patients with congenital heart disease. Experience from a reference centre]Jose Loureiro-Amigo, Nuria Fernández-Hidalgo, Antonia Pijuan-Domènech, et al.
International Journal of Antimicrobial Agents|May 11, 2019
Non-intravenous carbapenem-sparing antibiotics for definitive treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamase (ESBL) or AmpC β-lactamase: A propensity score studyYolanda Meije, Carles Pigrau, Núria Fernández-Hidalgo, et al.
Plos One|October 10, 2022
Persistent COVID-19 symptoms 1 year after hospital discharge: A prospective multicenter studyJudit Aranda, Isabel Oriol, Lucía Feria, et al.
Antibiotics (Basel, Switzerland)|May 27, 2023
Changing Trends in the Global Consumption of Treatments Used in Hospitalized Patients for COVID-19: A Time Series Multicentre StudyJudit Aranda, Jose Loureiro-Amigo, Anna Murgadella, et al.
Frontiers in Medicine|March 17, 2022
Methylprednisolone Pulses in Hospitalized COVID-19 Patients Without Respiratory Failure: A Randomized Controlled TrialIñigo Les, Jose Loureiro-Amigo, Ferran Capdevila, et al.
Plos One|January 21, 2022
Use of glucocorticoids megadoses in SARS-CoV-2 infection in a spanish registry: SEMI-COVID-19Cristina Lavilla Olleros, Cristina Ausín García, Alejandro David Bendala Estrada, et al.
Pageof 2